{
  "docId": "019dd923-622c-750b-8b9a-2a2468219173",
  "docSlug": "ce565b841c40",
  "documentTitle": "Nevro Corp. (NVRO)",
  "authorId": "58_Scorpion_Capital",
  "authorName": "Kir Kahlon",
  "documentKindSlug": "activist-deck",
  "documentKindLabel": "Activist deck",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2021-01-07 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.3333334,
  "pageNumber": 221,
  "pageCount": 239,
  "prevPage": 220,
  "nextPage": 222,
  "slideType": "villain_critique",
  "function": "name_villain",
  "density": "overcrowded",
  "nDataPoints": 0,
  "notes": "The slide uses a 'villain critique' approach by framing the company's business model as exploitative and unsustainable.",
  "elementsJson": [
    "headline_text",
    "paragraph",
    "quote_block",
    "footnote"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b9a-2a2468219173/221",
  "deckHref": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-221",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "This kind of aggressive rep behavior goes on a lot. That's a big part of the business and I think it's incentivized as a big part of the business. Wink-wink, not verbally. The companies say it's all about the patient. It has nothing to do with the patient.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd953-3f3d-76db-b34a-428d42f8f798",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.9,
        "x": 0.05,
        "y": 0.13
      },
      "kind": "paragraph",
      "text": "A former Nevro district manager, one of the longest tenured reps in the stimulator space, detailed toxic incentives and a company culture of “over-aggressive” reps pushing trials and stimulators when not indicated.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "882bad46-e32c-4ef9-82c3-fcf4d60674f5",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.9,
        "x": 0.05,
        "y": 0.41
      },
      "kind": "quote",
      "text": "I would say a third of Nevro’s business is driven by these patients that are being pushed into a stimulator by an over-aggressive rep. One-third of patients are the perfect candidate, one-third are 50/50, and one-third aren't good candidates.",
      "attrs": null,
      "subkind": "testimonial",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1994686b-f2b4-49e9-b0d9-2e8b6821b7ec",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.9,
        "x": 0.05,
        "y": 0.53
      },
      "kind": "quote",
      "text": "You have the new pharma rep who drinks the Kool-Aid... This kind of aggressive rep behavior goes on a lot. That's a big part of the business and I think it's incentivized as a big part of the business. Wink-wink, not verbally.",
      "attrs": null,
      "subkind": "testimonial",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "acbd1441-37d5-4c06-92ac-9427dccbc36e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.9,
        "x": 0.05,
        "y": 0.7
      },
      "kind": "quote",
      "text": "How reps get paid is trial to perm... They don't measure based upon patient satisfaction. They measure the way you close your sales. I get it. I'm not arguing with that. That's just the way that it is.",
      "attrs": null,
      "subkind": "testimonial",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bd9a23a0-74bf-41b9-a940-cbc607f61174",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "quote",
      "text": "I would say a third of Nevro’s business is driven by these patients that are being pushed into a stimulator by an over-aggressive rep. One-third of patients are the perfect candidate, one-third are 50/50, and one-third aren't good candidates. — Former Nevro district sales manager",
      "attrs": null,
      "subkind": null,
      "toolName": "Authority citation",
      "toolSlug": "authority-citation",
      "confidence": null,
      "componentId": "019dd953-3f3d-76db-b34a-46bede0a1c0b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.2,
        "x": 0.05,
        "y": 0.96
      },
      "kind": "source-note",
      "text": "Source: Consultation calls with experts",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "007184ca-e1dd-4804-a485-41d8859d69f8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.9,
        "x": 0.05,
        "y": 0.09
      },
      "kind": "title",
      "text": "Over-utilization, unnecessary implants, and patient exploitation are key drivers of Nevro's sales",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "616e3708-5d4c-4fea-81ca-7bf9afc9e9a1",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.4,
        "x": 0.05,
        "y": 0.04
      },
      "kind": "title",
      "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d5c0027d-0e6b-4aaa-958d-883cf3456b58",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "antagonist-introduction",
      "slug": null,
      "matchId": "f9aeb620-779d-4f00-83e7-ede58602b25a",
      "evidence": "The slide frames the company's sales practices as exploitative and unethical.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}